Advisory Services Network’s Beam Therapeutics BEAM Stock Holding History

Advisory Services Network’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.12K	Buy	+173	New	+$4.8K	﹤0.01%	3931
2024 Q1	–	Sell	-476	Closed	-$13K	–	1677
2023 Q4	$13K	Buy	+476	New	+$11.8K	﹤0.01%	2744
2023 Q2	–	Sell	-130	Closed	-$3.98K	–	1662
2023 Q1	$3.98K	Hold	130	–	–	﹤0.01%	3226
2022 Q4	$5.08K	Buy	+130	New	+$5.82K	﹤0.01%	3123
2021 Q3	–	Sell	-75	Closed	-$10K	–	1573
2021 Q2	$10K	Buy	+75	New	+$5.98K	﹤0.01%	2779

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Advisory Services Network's BEAM Position: Q1 2026 in Review

Advisory Services Network opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 173 shares worth $4.12K. The stake represents ﹤0.01% of the portfolio and ranks #3931 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in BEAM as recently as Q4 2023.

Advisory Services Network first reported a position in BEAM in Q2 2021 and has held it in 5 quarters since. The position peaked at $13K in Q4 2023. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Advisory Services Network held 173 shares of Beam Therapeutics worth $4.12K as of Q1 2026.
Beam Therapeutics was a new Advisory Services Network position in Q1 2026.
Beam Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3931 holding.
Advisory Services Network first reported a position in Beam Therapeutics in Q2 2021 and has held it in 5 quarters since.
Advisory Services Network's Beam Therapeutics position peaked at $13K in Q4 2023.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.